Nakoda Biocontrols Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-12-2024
- Paid Up Capital ₹ 0.10 M
as on 07-12-2024
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -24.20%
(FY 2022)
- Profit -87.92%
(FY 2022)
- Ebitda -32.81%
(FY 2022)
- Net Worth 7.03%
(FY 2022)
- Total Assets -4.26%
(FY 2022)
About Nakoda Biocontrols
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sandeep Jain and Jinoo Jain serve as directors at the Company.
- CIN/LLPIN
U24211GJ2010PTC061575
- Company No.
061575
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jul 2010
- Date of AGM
20 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Nakoda Biocontrols Private Limited offer?
Nakoda Biocontrols Private Limited offers a wide range of products and services, including Insecticides and Pesticides, Termiticide, Fungicides, Selective Herbicide.
Who are the key members and board of directors at Nakoda Biocontrols?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Jain  | Director | 14-Jul-2010 | Current |
| Jinoo Jain | Director | 02-Jan-2019 | Current |
Financial Performance of Nakoda Biocontrols.
Nakoda Biocontrols Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 24.2% decrease. The company also saw a substantial fall in profitability, with a 87.92% decrease in profit. The company's net worth moved up by a moderate rise of 7.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nakoda Biocontrols?
Unlock access to Nakoda Biocontrols's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Khyati Agrigenetics Private LimitedActive 1 year 4 monthsSandeep Jain and Jinoo Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nakoda Biocontrols?
Unlock and access historical data on people associated with Nakoda Biocontrols, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nakoda Biocontrols, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nakoda Biocontrols's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
